Research Updates


  • Tumor Testing May Help Guide Pancreatic Cancer Treatment

    For a small group of pancreatic cancer patients who were able to receive therapies targeting the molecular alterations in their tumors, these matched therapies were associated with longer life.

    by Cheryl Platzman Weinstock

  • Cancer Treatment During a Pandemic

    People being treated for cancer may be at elevated risk of developing severe cases of COVID-19. The coronavirus is also affecting how cancer care is delivered.

    by William G. Nelson, MD, PhD

  • Testing Cancer Patients for the Coronavirus

    Cancer centers are taking advantage of their in-house molecular laboratories to selectively test certain cancer patients for the coronavirus.

    by Anna Azvolinsky

  • Q&A

    A Different Mountaintop

    Science writer Charles Graeber describes how a shift in researchers' understanding of immune function and cancer is leading to effective treatments.

    by Marci A. Landsmann

  • Forward Look

    New Guidelines for Radiation Therapy in Pancreatic Cancer

    Recommendations address conflicts and research gaps.

    by Ashley P. Taylor

  • Forward Look

    Managing Opioid-Related Constipation

    Patients may be wary of discussing this common side effect.

    by Sue Rochman

  • Can CRISPR Deliver?

    A gene-editing tool called CRISPR holds promise for treating cancer. What does the new technology mean for patients?

    by Stephen Ornes

  • The Puzzle of Pancreatic Cancer

    Pancreatic cancer remains a difficult disease to treat and is expected to be the second leading cause of U.S. cancer-related deaths by 2030. Researchers hope clinical trials and insights into the genetics of the disease will reverse the trend.

    by Kendall K. Morgan

  • The Coronavirus Impacts Cancer Clinical Trials

    The National Cancer Institute and the Food and Drug Administration have provided guidance for managing clinical trials amid the spread of the novel coronavirus. Cancer centers are making changes to care for some patients enrolled in trials.

    by Anna Azvolinsky

  • From the Editor-in-Chief

    Cancer Epigenetics: Disorganization Drives Dysfunction

    Emerging insights into epigenetic abnormalities in cancer cells may lead to better cancer outcomes.

    by William G. Nelson, MD, PhD